Psoriatic arthritis trials in Finland

1 trial · From EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Finland
  A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)

  Where

  Kuopio

  Age

  18 years and over

  People

  948 worldwide

  Run by

  MoonLake Immunotherapeutics AG

  See details and how to join2025-522471-28-00